» Articles » PMID: 3262628

Interleukin 1-dependent Paracrine Granulopoiesis in Chronic Granulocytic Leukemia of the Juvenile Type

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1988 Oct 1
PMID 3262628
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Marrow and peripheral blood cells from nine children with juvenile chronic granulocytic leukemia (JCGL) demonstrated intense (94 +/- 16% maximum) spontaneous granulocyte/macrophage colony growth but cells from five children with the adult variety of CGL did not. This unusual pattern of colony growth depended upon a stimulatory protein(s) produced by mononuclear phagocytes. No GM-CSA activity was found in any chromatofocused fraction of JCGL monocyte-conditioned media but an activity that induced GM-CSA in umbilical vein endothelial cells was detected at pI 6.9-7.2. Moreover, the CSA-inducing monokine was neutralized by an anti-IL-1 antibody in vitro and, in the one case so tested, the same antibody also inhibited "spontaneous" colony growth. Therefore granulocyte/macrophage colony growth in JCGL is characteristically abnormal and distinguishes JCGL from the adult form of the disease. This abnormality depends upon the production, by mononuclear phagocytes, of IL-1 which, in turn, stimulates the release of high levels of colony stimulating activity by other cells. The high proliferative activity of CFU-GM we found in JCGL patients, and the high levels of GM-CSA found in their serum are compatible with the view that the in vitro abnormality reflects a similar abnormality in vivo.

Citing Articles

Progression and perspectives in disease modeling for Juvenile myelomonocytic leukemia.

Fu S, Guo Y, Peng Z, Zhang D, Chang Z, Xiao Y Med Oncol. 2024; 42(1):25.

PMID: 39652257 PMC: 11628578. DOI: 10.1007/s12032-024-02549-5.


Modeling (not so) rare developmental disorders associated with mutations in the protein-tyrosine phosphatase SHP2.

Solman M, Woutersen D, den Hertog J Front Cell Dev Biol. 2022; 10:1046415.

PMID: 36407105 PMC: 9672471. DOI: 10.3389/fcell.2022.1046415.


Inflammatory response in hematopoietic stem and progenitor cells triggered by activating SHP2 mutations evokes blood defects.

Solman M, Blokzijl-Franke S, Piques F, Yan C, Yang Q, Strullu M Elife. 2022; 11.

PMID: 35535491 PMC: 9119675. DOI: 10.7554/eLife.73040.


Induced Pluripotent Stem Cells to Model Juvenile Myelomonocytic Leukemia: New Perspectives for Preclinical Research.

Wehbe Z, Ghanjati F, Flotho C Cells. 2021; 10(9).

PMID: 34571984 PMC: 8465353. DOI: 10.3390/cells10092335.


Current Treatment of Juvenile Myelomonocytic Leukemia.

Mayerhofer C, Niemeyer C, Flotho C J Clin Med. 2021; 10(14).

PMID: 34300250 PMC: 8305558. DOI: 10.3390/jcm10143084.


References
1.
Chervenick P, LoBuglio A . Human blood monocytes: stimulators of granulocyte and mononuclear colony formation in vitro. Science. 1972; 178(4057):164-6. DOI: 10.1126/science.178.4057.164. View

2.
Zsebo K, Yuschenkoff V, Schiffer S, Chang D, McCall E, Dinarello C . Vascular endothelial cells and granulopoiesis: interleukin-1 stimulates release of G-CSF and GM-CSF. Blood. 1988; 71(1):99-103. View

3.
Altman A, Palmer C, Baehner R . Juvenile "chronic granulocytic" leukemia: a panmyelopathy with prominent monocytic involvement and circulating monocyte colony-forming cells. Blood. 1974; 43(3):341-50. View

4.
Altman A, Baehner R . In vitro colony-forming characteristics of chronic granulocytic leukemia in childhood. J Pediatr. 1975; 86(2):221-4. DOI: 10.1016/s0022-3476(75)80472-0. View

5.
Millard R, Okell S . The effect of cytosine arabinoside in vitro on agar colony forming cells and spleen colony forming cells of C57BL mouse bone marrow. Cell Tissue Kinet. 1975; 8(1):33-40. DOI: 10.1111/j.1365-2184.1975.tb01204.x. View